Another cancer type in which SETD2 plays an important role is Sporadic clear cell renal cell carcinoma (cRCC), where frameshift, non-sense and missense mutations in SETD2 were observed, suggesting a loss-of-function mechanism21. Here, SETD2 is linked to clear cell renal carcinoma.